3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield Several stocks are lifting their dividends, while one small pharma company just declared a special dividend that gives it a huge dividend yield. MarketBeat · Apr 16, 2025
Ex-NYC COVID adviser is fired after video reveals he attended parties during pandemic A former New York City official who helped coordinate the city’s response to the pandemic has been fired from his private-sector job The Independent UK · Sep 24, 2024
3 Small-Cap Healthcare Stocks With Breakthrough Potential The healthcare industry is growing massively owing to new drugs and technological innovations. Thus, investing in fundamentally robust small-cap stocks Theratechnologies (THTX), Anika Therapeutics. (ANIK), and SIGA Technologies (SIGA) could be a good idea. Read more to find out…. StockNews.com · Aug 15, 2024
12 Health Care Stocks Moving In Friday's After-Market Session Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. Benzinga · Jul 29, 2022
Pharma Firm SIGA Cashes In On Monkeypox Scare New York-based pharmaceutical firm SIGA Technologies (NASDAQ: SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox. Benzinga · May 25, 2022
Why SIGA Technologies Stock Is Surging SIGA Technologies Inc (NASDAQ: SIGA) shares are trading higher Monday morning following increased social media interest amid elevated concerns surrounding a monkeypox outbreak. Benzinga · May 23, 2022
Why SIGA Technologies Shares Are Trading Higher Today? The FDA approved the intravenous (IV) formulation of SIGA Technologies Inc's (NASDAQ:SIGA) TPOXX for smallpox. The oral formulation of TPOXX (tecovirimat) is approved in the US, Canada, and Europe to treat smallpox. The European approval also includes the treatment of monkeypox, cowpox, and complications from immunization with vaccinia. The IV formulation of TPOXX was… Benzinga · May 19, 2022